PROGRAMME SUMMARY
ERA PerMed is an ERA-NET Cofund, supported by 32 partners of 23 countries and cofunded by the European Commission (EC). To align national research strategies, promote excellence, reinforce the competitiveness of European players in Personalised Medicine (PM), and enhance the European collaboration with non-EU countries, 33 funding organisations have agreed to launch the fifth Joint Transnational Call for collaborative innovative research projects in PM. This represents the fourth additional call non-cofunded by the EC. The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals.
Aims of the Call
Topic: Pharmacogenomic Strategies for Personalised Medicine Approaches (PGxPM2025)
The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).
EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe in this field.
The call will be implemented in two stages, i.e. a pre- and a full-proposal phase.
The EP PerMed JTC2025 Information Day takes place on 9 January, 2025, 13:00-14:30 CET
View full Call text on ERA PER MED website
FUNDING SPECIFICS
- The FNR supports this Call with 300,000 EUR.
- Overall budget for this Call is approx. 36.5 MEUR
APPLICATION INFORMATION
In addition to submitting at ERA PerMed, Luxembourg applicants must also submit the proposal – along with the FNR INTER documents – to the FNR no later than 7 working days after the ERA PerMed deadline(s).
Timeline
Time Event 16 December, 2024 Publication of the call 09 January 2025 JTC2025 information day 18 February, 2025 (14:00, CET) Deadline for pre-proposal submission Expected around 15 May, 2025 Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage 17 June, 2025 (14:00, CEST) Deadline for full-proposal submission Mid/end of August 2025 Rebuttal stage Expected for October 2025 Communication of the funding decisions to the ap-plicants End of 2025, beginning of 2026 Expected project start (according to region-al/national funding regulations)